GlassScriptPhysician profile
Michelle L Trapp
NPI 1053637108
$1,248.74
in general payments reported to CMS, 2019-2025
16 companies · $25.22 in 2025
The $25.22 reported for 2025 was less than what a typical Obstetrics & Gynecology (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $319 · 2022: $723 · 2023: $16.73 · 2024: $165 · 2025: $25.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $207.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $498.36 | 2022-2025 | |
| Galderma Laboratories, L.P. | $141.73 | 2023-2024 | |
| Amgen INC. | $115.87 | 2021-2022 | |
| Seagen INC. | $87.56 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $79.57 | 2021-2022 | |
| Epizyme, INC. | $66.58 | 2021 | |
| Hologic Sales and Service, LLC | $40.20 | 2024 | Thinprep 2000 Processor |
| Celgene Corporation | $35.68 | 2022 | |
| Genzyme Corporation | $33.65 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $30.49 | 2021 | |
| Daiichi Sankyo INC. | $29.36 | 2022 | |
| Dova Pharmaceuticals | $23.95 | 2021 | |
| Eisai INC. | $19.01 | 2022 | |
| Dendreon Pharmaceuticals LLC | $18.64 | 2022 | |
| Octapharma USA, INC. | $15.88 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $12.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Trapp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.